ENTO - Entero Therapeutics, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 0.395

Open

Bid

$ 0.37 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.19 - $ 22.20

Volume

49,618

Average Volume

Market Cap

977,661

Beta (5Y Monthly)

$ 1.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-29-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-20-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-23-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-24-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	11-16-2020	09-30-2020	10-Q
16	08-14-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	03-30-2020	12-31-2019	10-K
19	11-14-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-15-2019	03-31-2019	10-Q
22	04-01-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-13-2018	06-30-2018	10-Q
25	05-14-2018	03-31-2018	10-Q
26	03-16-2018	12-31-2017	10-K
27	11-13-2017	09-30-2017	10-Q
28	08-14-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-31-2017	12-31-2016	10-K
31	11-25-2016	09-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Friday, Entero Therapeutics Recei...
08/26/2024 07:20:39

Entero Therapeutics Files For Shelf Of Up ...
07/26/2024 20:21:10

- SEC Filing

Entero Therapeutics Announces Exercise Of ...
07/11/2024 12:05:57

Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO), a clinical-stage biopharmaceutical company...

Entero Therapeutics Publishes Innovative C...
06/27/2024 10:04:18

Entero Therapeutics, Inc., (NASDAQ:ENTO), ("Entero Therapeutics" or the "Company"), a clinical-stage biopharmac...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
06/12/2024 20:31:07

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
06/10/2024 20:31:12

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
06/10/2024 12:06:22

First Wave BioPharma Changes Name to Enter...
05/16/2024 11:30:57

Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (NASDAQ:ENTO) ("Entero" or the "Company"), a l...